Peptides→Weight & Metabolism
Weight & Metabolism Peptides
GLP-1 agonists, metabolic peptides, and compounds targeting fat loss and metabolic health
Retatrutide
Retatrutide
Retatrutide is a first-in-class triple agonist targeting GIP GLP-1 and glucagon receptors simultaneously developed by Eli Lilly. Phase 2 trial data pu...
Cagrilintide
Cagrilintide
Cagrilintide is a long-acting synthetic amylin analog developed by Novo Nordisk that is currently in Phase 3 clinical trials in combination with semag...
Amylin
Islet Amyloid Polypeptide (IAPP)
Amylin is a 37-amino-acid peptide hormone co-secreted with insulin by pancreatic beta cells in response to meals. It plays a complementary role to ins...
Mazdutide
Mazdutide (IBI362)
Mazdutide (IBI362) is a dual GLP-1 and glucagon receptor co-agonist developed by Innovent Biologics that has completed Phase 2 trials in China showing...
GLP-1
Glucagon-like Peptide-1
Glucagon-like Peptide-1 (GLP-1) is an endogenous incretin hormone secreted by L-cells in the small intestine in response to food intake. It plays a ce...
Liraglutide
Liraglutide
Liraglutide is a GLP-1 receptor agonist approved by the FDA for type 2 diabetes (Victoza) and obesity management (Saxenda). It was the first GLP-1 ana...
Semaglutide
Semaglutide
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes management and approved by the FDA under th...
Melanocyte Stimulating Hormone
Alpha-MSH (Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2)
Melanocyte Stimulating Hormone (alpha-MSH) is the 13-amino-acid endogenous peptide produced from POMC in the pituitary gland and skin that regulates p...
Tirzepatide
Tirzepatide
Tirzepatide is a first-in-class dual GIP/GLP-1 receptor agonist approved by the FDA under the brand name Mounjaro for type 2 diabetes and Zepbound for...
GHRP-2
Growth Hormone Releasing Peptide-2
GHRP-2 is considered one of the most potent growth hormone releasing peptides available. It stimulates GH release more effectively than GHRP-6 with le...
Tesamorelin
Tesamorelin Acetate
Tesamorelin is a synthetic GHRH analog that is FDA-approved for the treatment of HIV-associated lipodystrophy. It is the only GHRH peptide with full F...
GHRP-6
Growth Hormone Releasing Peptide-6
GHRP-6 is a synthetic hexapeptide that stimulates natural growth hormone release from the pituitary gland. It is known for its strong appetite-stimula...
Pemtutamide
Pemtutamide (GLP-1/GIP/Glucagon Triple Agonist)
Pemtutamide is an investigational triple receptor agonist targeting GLP-1 GIP and glucagon receptors developed by Pfizer for the treatment of obesity...
Sermorelin
Sermorelin Acetate (GRF 1-29 NH2)
Sermorelin is a truncated analog of natural GHRH containing the first 29 amino acids, which is the minimum fragment needed for full biological activit...
IGF-1 LR3
Insulin-like Growth Factor 1 Long R3
IGF-1 LR3 is a modified version of IGF-1 with 83 amino acids (vs. 70 in native IGF-1) and an arginine substitution at position 3. These modifications...
Melanotan II
Melanotan II Acetate
Melanotan II is a synthetic cyclic peptide analog of alpha-melanocyte stimulating hormone (α-MSH). It activates melanocortin receptors, producing effe...
Follistatin 344
Follistatin 344
Follistatin 344 is a naturally occurring glycoprotein that acts as an antagonist to myostatin, the protein that limits muscle growth. By neutralizing...
HGH Fragment 176-191
Human Growth Hormone Fragment 176-191
HGH Fragment 176-191 is the specific portion of the growth hormone molecule responsible for its fat-burning activity. This small peptide fragment repr...
Ipamorelin
Ipamorelin Acetate
Ipamorelin is one of the most selective growth hormone secretagogues available. Unlike other GH-releasing peptides, it stimulates GH release without s...
CJC-1295
CJC-1295 with Drug Affinity Complex (DAC)
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates pituitary growth hormone release. The DAC modification exten...
Ipamorelin + CJC-1295
Ipamorelin Acetate + Modified GRF 1-29
The Ipamorelin and CJC-1295 combination is one of the most widely used GH-stimulating peptide protocols in the research and wellness community. Ipamor...
CagriSema
Cagrilintide + Semaglutide (CagriSema)
CagriSema is a combination therapy from Novo Nordisk pairing semaglutide (GLP-1 agonist) with cagrilintide (long-acting amylin analog) in a single wee...
Survodutide
Survodutide (BI 456906)
Survodutide is a dual GLP-1/glucagon receptor agonist developed by Boehringer Ingelheim and Zealand Pharma. Its glucagon component drives the liver to...
Orforglipron
Orforglipron (LY3502970)
Orforglipron is a non-peptide, oral GLP-1 receptor agonist being developed by Eli Lilly. Unlike injectable GLP-1 drugs, it is a small molecule that su...